A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Golcadomide plus R-CHOP chemotherapy vs placebo plus R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (GOLSEEK-1)

  • Ghanem, Riad (Researcher)
  • Kausche, Lea (Researcher)
  • Klein, Katharina (Researcher)
  • Kovacsova, Judita (Researcher)
  • Krenosz, K. J. (Researcher)
  • Krivic, Denis (Researcher)
  • Kühr, Thomas (Researcher)
  • Lichtenauer, Nina (Researcher)
  • Piringer, Gudrun (Researcher)
  • Popp, Henning Detlef (Researcher)
  • Schneeweiß, Bruno (Researcher)
  • Schwarz, Heike (Researcher)
  • Solomianyi, Oleksii (Researcher)
  • Stegemann, Maike (Researcher)
  • Schmitt, Clemens (PI)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

A phase 3, multicenter, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Golcadomide plus R-CHOP chemotherapy vs placebo plus R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (GOLSEEK-1)
StatusActive
Effective start/end date25.06.2024 → 31.12.2027

Fields of science

  • 302024 Haematology
  • 302055 Oncology